Jim Tananbaum, in the year 2011, created a company that is dedicated in identifying healthcare leaders that were emerging and assisting them grows profitability. Jim achieved this by offering information, capital, and networks. The firm is known as Foresite Capital. This idea was born to Jim after his 25 years working as an entrepreneur and investment strategist in the healthcare department. While he was working, he discovered major success factors that will help companies and entrepreneurs. Most of what Jim learnt lies in the science of innovation and teamwork.
Jim understands the harness of the future of healthcare. He knows first-hand info that the innovative products needed in health care, in most cases, require more time and capital more than most entrepreneurs and financier appreciate. Thus, Foresite Capital is there to join hands with the innovators and help them in determining the most viable investments and then achieve the highest probability of success. The company has invested in 77 different healthcare companies in genomic sequencing, biopharmaceuticals, diagnostics, and Medical services.
According to Biz Journals, Jim comprehends that for an idea to come to life, it requires more than just capital. Plans need to be implemented by the smartest, most determined, and efficient leaders. Thus, when Jim meets with such a team, he helps them by offering a means that will enable them to make scientific discoveries that are critical as well as have the potential needed to make the greatest impact in the health care business. Jim enjoys his business and the fact that he deals with entrepreneurs that deal with the science behind the innovation of health care. He is fascinated how this science can help sold the unmet needs of healthcare.
In a report by INC42, Jim went to Yale University where he pursued Math and electrical engineering. He also attained a degree in Computer Science major from the same institution. Jim Tananbaum further perused his studied at Harvard where he was awarded M.B.A and M.D. From the Massachusetts Institute of Technology; he got his M.S. He started his career working at Sierra Ventures. He later joined other partners to create Prospect Venture Partners II and III. He was also a co-founder of the Theravance, INC and also a part of creating NASDAQ: GENS.GENS. The firm brought two medicines in the market with an $80 million Budget. The two companies have a combined market capitalization of around $3.2 billion.